Live Breaking News & Updates on Sequencing Therapy

Stay updated with breaking news from Sequencing therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sequencing Therapies in the Third-Line and Beyond Setting for MCL

A panel of experts discuss how to sequence BTK inhibitors and CAR T-cell therapies in patients with MCL. ....

Recent Updates , Follicular Lymphoma , Mantle Cell Lymphoma , Beyond Setting , Sequencing Therapy , Brexu Cel , Btk Inhibitor , Cart Cell Therapy , Liso Cel ,

Unmet Needs in Treating Relapsed/Refractory FL

Laurie Sehn, MD, and Bijal Shah, MD, discuss remaining unmet needs for patients with relapsed/refractory FL. ....

Bijal Shah , Laurie Sehn , Recent Updates , Follicular Lymphoma , Mantle Cell Lymphoma , Pod 24 , Tumor Microenvironment , Unmet Needs , Sequencing Therapy , Global Biology , Circulating Tumor Dna ,

Sequencing Immunotherapy in the Third-line and Beyond Setting for FL

Peter Martin, MD, discusses how to sequence bispecific T-cell engagers and CAR T-cell therapies in the third-line and beyond setting for FL. ....

Peter Martin , Recent Updates , Follicular Lymphoma , Mantle Cell Lymphoma , Beyond Setting , Patient Preference , Cellular Therapy , Clinical Factor , Real World Data , Quality Of Life , Bispecific Antibody , Cart Cell , Sequencing Therapy , Cart Cell Therapy ,

Overview of Second-Line Treatment Options in SCLC

Expert oncologists Laurent Greiller, MD, and Christian Grohé, MD, reflect on the current state of second-line treatment options for patients with small cell lung cancer. ....

Laurent Greiller , Christian Groh , Evolving Paradigms , Second Line Treatment Options , Small Cell Lung Cancer , Relapsed Refractory Sclc , Relapsed Refractory Small Cell Lung Cancer , Second Line Therapy , Second Line Treatment , Sequencing Therapy , Time To Progression , Maintenance Therapy , Trio Therapy , Treatment Response , Platinum Sensitive , Platinum Resistant , Treatment Rechallenge , Therapy Rechallenge , Imforte Trial , Imforte Study ,

Treatment Considerations for Patients with Newly Diagnosed Multiple Myeloma

Panelists share a brief discussion on the current treatment armamentarium available to patients with newly diagnosed multiple myeloma. ....

Unmet Needs , Provide Optimal Care , Multiple Myeloma , Newly Diagnosed Multiple Myeloma , Frontline Therapy , First Line Therapy , First Line Treatment , Combination Therapy , Triplet Therapy , Quadruplet Therapy , Maintenance Therapy , Multiple Myeloma Transplant , Adverse Events , Safety Profile , Sequencing Therapy , Novel Therapy ,